Untitled design 250px 500pxFDA Cleared Medical Device Improves Feeding Outcomes of Infants Born Prematurely

Olathe, KS and Rockville, MD, April 28, 2020—Innara Health, developer of the only FDA cleared medical device designed to improve the feeding outcomes of infants born prematurely, is partnering with BioHealth Innovation (BHI) to support the company’s plans for growth through greater market access and the development of NextGen technology.  Innara Health is dedicated to improving feeding outcomes for newborn and infants born prematurely.  “As we continue to expand our domestic footprint, we are very fortunate to call BHI our partner as their infrastructure and access will certainly support Innara in our journey to redesign the NTrainer, enter into adjacent markets, and expand globally” states Innara CEO Chris Mathia.  “We are excited to support Chris and his team as they expand, grow and develop new technology ultimately enabling many more NICU patients to return home to their families sooner and healthier” said BHI CEO Rich Bendis.

Innara Health’s solution, the NTrainer, is designed to improve oral coordination in newborns and infants born prematurely, helping them develop the skills needed to safely advance to oral feeding. Delayed, or failure to advance to oral feeding impacts clinical outcomes and often is cited as a reason for an extended length of stay in the NICU.   In a recently published multi-center clinical study, the NTrainer successfully reduced time to achieve independent oral feeds in infants born prematurely by 4 days, while also reducing length of stay by 6 days.  The proliferation of clinical research surrounding challenges with neonatal feeding supports a growing interpretation that feeding development is about more than simply receiving nutrition.  When critical pre-feeding skills are strengthened, the outcome is beneficial for a newborn’s neurological and physiological development. 

Innara Health is a leader in feeding health technology and dedicated to advancing the global understanding and improvement of neonatal feeding. In working towards this goal Innara Heath has developed the FDA cleared NTrainer System®. The NTrainer is an advancement for oral feeding development as it fosters skills essential to the development of oral feeding in newborns and infants born prematurely. Innara Health continues to work towards creating cutting edge products that improve standards of care, optimize patient outcomes, and increase healthcare benefits for feeding health. www.innarahealth.com

BioHealth Innovation, Inc. (BHI) is a nonprofit organization focused on accelerating biohealth technology commercialization in the BioHealth Capital Region (BHCR).  In addition to promoting the BHCR region (Maryland, DC, and Virginia) and its larger industry leaders, BHI’s team of Entrepreneurs-in-Residence, venture analysts, and other professional staff support early stage biohealth companies with market research and commercialization plan development; non-dilutive funding application assistance; introductions to investors, strategic partners, business advisors, and potential clients. BHI also offers soft-landing support for international companies, assists companies seeking lab space, and co-hosts an annual BHCR Forum and BHCR investor partnering conference. www.biohealthinnovation.org

Press Contact  
Chris Mathia, CEO, Innara Health
913-742-4456; This email address is being protected from spambots. You need JavaScript enabled to view it.